about
Homogeneous Biosensing Based on Magnetic Particle LabelsPredictive biomarkers for treatment selection: statistical considerationsAcute kidney injury: preclinical innovations, challenges, and opportunities for translationBiomarkers in nephrology: Core Curriculum 2013Established and emerging markers of kidney functionThe role of drug transporters in the kidney: lessons from tenofovirPro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapyCardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicabilityThe urine microRNA profile may help monitor post-transplant renal graft function.Acoustic radiation force impulse imaging for noninvasive evaluation of renal parenchyma elasticity: preliminary findingsLongitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic NephropathyPerformance Characteristics of Kidney Injury Molecule-1 In Relation to Creatinine, Urea, and Microalbuminuria in the Diagnosis of Kidney DiseaseA comparison of the ability of levels of urinary biomarker proteins and exosomal mRNA to predict outcomes after renal transplantation.Serum levels of WNT1-inducible signaling pathway protein-1 (WISP-1): a noninvasive biomarker of renal fibrosis in subjects with chronic kidney disease.Common variants in UMOD associate with urinary uromodulin levels: a meta-analysisDevelopment of glomerulus-, tubule-, and collecting duct-specific mRNA assay in human urinary exosomes and microvesicles.Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans.Integrative biology identifies shared transcriptional networks in CKD.A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers.Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker dataLow-level cadmium exposure and effects on kidney function.Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses.Metal-on-metal hip prostheses and systemic health: a cross-sectional association study 8 years after implantationUrine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity.Preliminary study of Huai Qi Huang granules delay the development of primary glomerular diseases in human.Urinary biomarkers at early ADPKD disease stageSerum cystatin C - marker of inflammation and cardiovascular morbidity in chronic kidney disease stages 1-4Parental history of premature cardiovascular disease, estimated GFR, and rate of estimated GFR decline: results from the Aerobics Center Longitudinal Study.Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKDPlasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomographyComparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine.Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100/RAGE and FGF23.B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension.Albuminuria and its associated biomedical factors among indigenous adults in Far North Queensland: a 7-year follow up study.Molecular phenotyping of clinical AKI with novel urinary biomarkers.Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl.Unexpected Normal Colloid Osmotic Pressure in Clinical States with Low Serum Albumin.MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
P2860
Q26747505-61C65DB9-AE38-45EE-AFF7-8B4958752A49Q26778367-49DAF364-D1D8-4C96-9DCF-27FC2B7A40FFQ26786667-8797DE35-427E-4B49-AED0-52B7CFD4C956Q26861451-9D8A10EB-2D4D-4D22-A3C7-6C8426AB469AQ26864498-1399F133-9089-4278-B8FF-77AB6858997BQ26866489-F18F5BC7-F3D5-4B91-AB53-D6DF759215F8Q27015909-C7EA36F2-ED20-485D-8E68-56A27F5BAC93Q28081407-9F56C216-715A-4C67-9E6D-B60306743756Q30411597-5734740D-4D28-490B-AD90-7D182691B02DQ30452095-87D97271-A96B-464C-A9ED-210721D596E9Q33556532-E434C2B2-843E-46A9-9876-5FAF3AC74AF8Q33718114-274B9E47-0CD1-42DE-8CAF-C1A36C854983Q33740157-D57A116F-FC4F-4B63-AEA3-7156B127C9B8Q33850279-D2E23C5F-12FB-458C-9225-C3E153E0D478Q33974623-A9B57EDD-D418-4550-BFC0-26EBDA9E2BD4Q34282212-D877AF16-D6D2-498E-BE02-DA589B1F31FAQ34369626-11930632-763A-4065-B63F-71AE9443A477Q34409745-4E9B81EE-3D59-4F82-8AC6-596F45D26E16Q34427636-995F857B-30ED-47A5-ABDD-CA0CAD7A60FEQ34502689-C01FBFA7-9B57-4B43-87EC-20E1EA1CB70DQ34552696-CE3C8E79-9341-43CC-A39C-BB25CD815255Q34607577-E58E37E0-3D9B-4D80-AE02-19EF980A189BQ34695711-E851012C-A488-4A4C-A656-E9ED5B3684F4Q34770577-5BD95878-1E68-4DD7-9BB6-581BB26C919FQ35159319-BCA929F2-1E03-4DC1-92A2-B8733E987C5BQ35176319-8B7A2576-8F85-46A9-AC75-6242E95FDA85Q35269939-E58AF80E-7A99-4915-A5E2-E08ACCACA5E1Q35392624-E21D32B1-9B91-4C14-A711-FB6BB8414F20Q35508233-617B62AC-7976-4C7C-AF5B-1F64E0E955B2Q35554050-088F79E5-726D-4A2D-A7F7-98802120B280Q35576138-EAB4DCEF-9390-4D62-9586-33CA67C6091FQ35626471-C4E70E70-A387-4046-B954-7DAFFB98AEBDQ35712111-3F245935-ED7F-498B-89CB-89E17BBDBFA5Q35737906-230A58FC-F698-4A7F-9511-A1B58DC7335BQ35742577-C248DCC2-9A09-4F71-B96F-E137F3DE6E59Q35864610-C3D9EAE4-505D-43F8-8CF7-8A2A39EF8287Q36017608-6B0E6586-A4A9-4ECA-9101-53704892A277Q36083217-3E73D5EF-ABB1-4082-AEC9-CE09C42B2B0DQ36084415-73A1C450-09D5-4748-B124-17E0520E1568Q36166755-BE99EC84-42A4-4419-ADA6-69CE79D02880
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarkers in chronic kidney disease: a review.
@en
Biomarkers in chronic kidney disease: a review.
@nl
type
label
Biomarkers in chronic kidney disease: a review.
@en
Biomarkers in chronic kidney disease: a review.
@nl
prefLabel
Biomarkers in chronic kidney disease: a review.
@en
Biomarkers in chronic kidney disease: a review.
@nl
P50
P356
P1433
P1476
Biomarkers in chronic kidney disease: a review.
@en
P2093
Glenda C Gobe
Robert G Fassett
P2888
P304
P356
10.1038/KI.2011.198
P407
P577
2011-06-22T00:00:00Z